Physician profile
Faisal Rahman
NPI 1215293311
$35,965.40
in general payments reported to CMS, 2019-2025
21 companies · $6,096 in 2025
The $6,096 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $24K · 2021: $529 · 2022: $929 · 2023: $1,122 · 2024: $2,550 · 2025: $6,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,096 · Travel and Lodging: $4,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,095.62 |
| Travel and Lodging | $4,672.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21,146.94 | 2019-2020 | |
| Medtronic, INC. | $4,429.29 | 2021-2025 | Corevalve Evolut R, Cg Future |
| Edwards Lifesciences Corporation | $2,942.46 | 2020-2025 | Evoque, Pascal |
| Abbott Laboratories | $2,441.02 | 2021-2025 | Triclip, Nc Trek Neo, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $2,059.82 | 2019-2025 | Watchman |
| Medical Device Business Services, INC. | $777.02 | 2024 | Carto 3 |
| Abiomed | $662.80 | 2023-2025 | Impella |
| Terumo Medical Corporation | $424.44 | 2019-2023 | Angio-Seal, Glidewire, Optitorque |
| Astrazeneca Pharmaceuticals LP | $202.08 | 2019 | |
| Shockwave Medical, INC | $175.88 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.14 | 2019-2025 | Lifevest |
| Pfizer INC. | $141.73 | 2019-2025 | |
| Acist Medical Systems, INC. | $126.78 | 2019 | |
| Novartis Pharmaceuticals Corporation | $87.34 | 2023 | |
| Amgen INC. | $58.60 | 2022-2024 | Repatha |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $37.45 | 2023 | Assure Wcd |
| Philips North America LLC | $24.59 | 2024 | (9266) Elca |
| Janssen Pharmaceuticals, INC | $23.79 | 2022 | |
| Cordis US Corp. | $20.16 | 2023 | Mynxgrip |
| W. L. Gore & Associates, INC. | $19.64 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cardiovascular Systems INC. | $18.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.